Copy Link Print Information

GSK2656157

65 Cited Publications
Customer Review

Based on 65 publication(s) in Google Scholar

GSK2656157 is a selective and ATP-competitive inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) with an IC50 of 0.9 nM.

For research use only. We do not sell to patients.

  • Purity: 99.66%
  • CAS No.: 1337532-29-2
  • Formula: C23H21FN6O
  • Molecular Weight:416.45
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 1 year , -20°C, 6 months
  • GSK2656157 Chemical Structure
    GSK2656157 Chemical Structure
  • Experimental Validation Results for GSK2656157
  • Experimental Validation Results for GSK2656157
  • Experimental Validation Results for GSK2656157
  • Experimental Validation Results for GSK2656157
CAS No.: 1337532-29-2
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Protocol
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) GSK2656157

More
Customer Validation & Images
WB
  • WB
  • WB
  • WB
  • WB
Keywords
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • GSK2656157 Chemical Structure
    GSK2656157 Chemical Structure
    1/16
  • 1/16

    GSK2656157 purchased from MedChemExpress. Usage Cited in: J Steroid Biochem Mol Biol. 2021 Jul:211:105893. [Abstract]

    Customer Validation
     Pretreatment with GSK2656157 (1 μM) alleviated the NEFA-induced increase in protein abundance and mRNA levels of PERK, eIF2α, ATF4, and CHOP vis a vis treatment with 1.2 mM NEFA alone.

  • 1/16

    GSK2656157 purchased from MedChemExpress. Usage Cited in: Oxid Med Cell Longev. 2020 Jul 27;2020:8291413. [Abstract]

    Customer Validation
     GSK2656157 not only inhibits the expression of p-PERK, but also reduces the expression of NRF2 in the nucleus (n-NRF2) and total NRF2 (t-NRF2) proteins.

  • 1/16

    GSK2656157 purchased from MedChemExpress. Usage Cited in: J Neuroinflammation. 2017 May 11;14(1):104. [Abstract]

    Customer Validation
     GSK2656157 treatment suppresses PERK autophosphorylation and TXNIP expression; STF083010 treatment inhibits IRE1α endonuclease activity and TXNIP expression. Representative Western blot and densitometric quantification of protein band optical densities for p-PERK, p-eIF2α/eIF2α, ATF-5, ChREBP, splicing XBP1 (sXBP1) and TXNIP. TXNIP expression is downregulated by GSK2656157 and STF083010 treatment.

  • 1/16

    GSK2656157 purchased from MedChemExpress. Usage Cited in: Int J Mol Sci. 2017 Apr 18;18(4). pii: E854. [Abstract]

    Customer Validation
     GSK2656157 treatment suppresses TXNIP expression and the number of TUNEL-positive cells. TXNIP expression is significantly suppressed by the GSK2656157 (300 μg) treatment.

  • GSK2656157